Since the COVID-19 outbreak, Chinese central SOEs have been making all-out efforts to support the battle against the virus not only in medical material production and development but also by transporting supplies to the front-lines, and in other ways as well.
China National Pharmaceutical Group Co., Ltd. (Sinopharm) has used its technology and capacity advantages to develop and produce nucleic acid diagnostic reagents soon after the outbreak of novel coronavirus.
- Timeline of China Releasing Information on COVID-19 and Advancing International Cooperation
- China Seeks International Cooperation in Anti-COVID-19 Research Projects
- Over 11m in Beijing Given COVID-19 Tests
- Beijing Reports Single-Digit COVID-19 Cases for Seven Consecutive Days